Overview

Higher vs. Lower Dose Heparin for PCI

Status:
Not yet recruiting

Trial end date:
2023-05-01

Target enrollment:

Participant gender:

Summary

HD PCI is a multicenter, randomized, registry-based, cluster crossover design trial of higher dose versus lower dose heparin in patients undergoing elective percutaneous coronary intervention (PCI).

Phase:

N/A

Details

Lead Sponsor:

Population Health Research Institute

Treatments:

Calcium heparin
Heparin